Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1402
Supernus Pharmaceuticals, Inc.
54.730
0
+0.48%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.48%
Monthly Change
+10.77%
6 month change
+1.35%
Year Change
+1.35%
Previous Close
54.470
0
Open
54.730
0
Bid
Ask
Low
54.730
0
High
54.730
0
Volume
97
Markets
US Stock Market
Healthcare
SUPN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
52.92 M
53.39 M
54.38 M
54.73 M
55.81 M
—
Valuation ratios
Enterprise value
1.04 B
1.35 B
1.94 B
1.44 B
1.95 B
7.88 B
Price to earnings ratio
10.66
29.76
36.03
1 386.5
27.39
-56.25
Price to sales ratio
2.6
2.73
3.46
2.53
3.06
12.4
Price to cash flow ratio
9.76
12.47
19.78
13.86
11.77
69.6
Price to book ratio
1.81
1.94
2.61
1.67
1.95
3.48
Enterprise value to EBITDA ratio
5.08
9.7
3.7
3.14
3.57
34.66
Profitability ratios
Return on assets %
0.08
0.03
0.04
0
0.05
0
Return on equity %
0.17
0.07
0.07
0
0.07
0
Return on invested capital %
56.82
21.61
12.96
0.78
22.24
11.91
Gross margin %
89.92
87.05
86.93
86.21
88.23
354.45
Operating margin %
33.38
14.84
6.91
0.87
12.34
19.1
EBITDA margin %
39.42
24.06
78.86
75.63
82.45
90.12
Net margin %
24.39
9.21
9.1
0.22
11.16
0.27
Liquidity ratios
Quick ratio
2.37
1.63
0.93
1.43
2.16
8.32
Current ratio
2.57
1.91
1.07
1.7
2.35
9.16
Inventory turnover
1.4
1.12
0.98
0.99
1.18
1.36
Asset turnover
0.39
0.36
0.39
0.41
0.5
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.22
0
0
—
—
Long term debt to total equity ratio
0.49
0.46
0
0
—
—
Per share metrics
Operating cash flow per share
2.58
2.34
1.89
2
3.07
1.28
EBIT per share
3.48
1.97
7.14
6.75
8.31
1.08
EBITDA per share
3.82
2.57
8.53
8.28
9.75
2.6
Total debt per share
—
—
—
—
—
—
Cash per share
7.87
6.25
7.48
4.59
1.24
8.56
Net current asset value per share
11.74
11.07
11.9
8.88
12.26
48.18
Tangible book value per share
5.64
-1.59
1.08
3.69
7.09
28.14
Working capital per share
7.18
5.27
0.75
3.66
7.04
26.97
Book value per share
13.87
15.01
14.37
16.6
18.51
74.43
News
TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch
Supernus Pharmaceuticals stock hits 52-week high at $57.76
Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains
Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates
Supernus earnings missed by $0.48, revenue topped estimates
Supernus faces earnings test after Q3 shock to profitability
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View
New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings
Supernus - Outlook For 2026 Positive, Upholding Buy Rating (NASDAQ:SUPN)
Supernus Pharmaceuticals amends merger agreement to adjust milestone payments
Cantor Fitzgerald reiterates Overweight rating on Supernus Pharmaceuticals stock